
Sign up to save your podcasts
Or


In the second portion of our two part-series on AML maintenance, Anthony and Bernie delve into the studies of post-transplant FLT3 inhibitor maintenance. We discuss the controversial MORPHO study of gilteritinib and whether these results will change practice!
By Bernard Marini, Anthony Perissinotti, et al.4.5
3030 ratings
In the second portion of our two part-series on AML maintenance, Anthony and Bernie delve into the studies of post-transplant FLT3 inhibitor maintenance. We discuss the controversial MORPHO study of gilteritinib and whether these results will change practice!

38,062 Listeners

25,797 Listeners

87,529 Listeners

111,948 Listeners

56,508 Listeners

188 Listeners

10,282 Listeners

7,230 Listeners

51 Listeners

8 Listeners

15,950 Listeners

10,745 Listeners

51 Listeners

195 Listeners

736 Listeners